Synopsis:
The anti-cancer activity of Tillandsia recurvata was
evaluated. The crude extract demonstrated anti-proliferation
activity, killing > 50% of the cells at a concentration
of 2.5 μg/ml. Kaposi sarcoma tumours were
inhibited by 75% compared to control in vivo (p <
0.05).